Filing Details

Accession Number:
0001181431-13-046422
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-08-26 13:18:01
Reporting Period:
2013-08-22
Filing Date:
2013-08-26
Accepted Time:
2013-08-26 13:18:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1552095 Min Yin 950 Tower Lane, Suite 900
Foster City CA 94404
Vp Compliance & Internal Audit No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-22 10,938 $4.21 10,938 No 4 M Direct
Common Stock Disposition 2013-08-22 10,938 $5.50 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2013-08-22 10,938 $0.00 10,938 $4.21
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,062 2021-10-31 No 4 M Direct
Footnotes
  1. Granted under the Issuer's 2005 Equity Incentive Plan.
  2. 25% of such shares vest one year from the grant date of October 31, 2011, and 2.0833% vests each month thereafter, provided that the Reporting Person continues to be employed by the Issuer.